Finance
Protein-diagnostics company completes $3.9 million series A funding round
Published in Proteomics Weekly, December 12th, 2005
The investor leading this round is Carmel-based Spring Mill Venture Partners, with Massachusetts-based Village Ventures as a coinvestor. As part of the financing, Ken Green, MD, managing partner of Spring Mill Ventures, has joined QuadraSpec's board of directors. All other investors in this round are individuals from Indiana.
The majority of the funds will be used to build QuadraSpec's manufacturing capabilities and to further develop a device that has the ability to perform advanced blood...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
Source: Proteomics Weekly (2005-12-12)
More Articles from Proteomics Weekly
- Drug Development
Mechanism of action of multi-functional class of defense proteins discussed - Granulosa Cells
Granulosa cell apoptosis not initiated by changes in oxidative stress-response proteins - Proteomics
Downregulation of c-myc protein occurs by siRNA-mediated silencing of DNA-PKcs in HeLa cells - Proteomics
Inhibitory PAS proteins are negative regulators of hypoxia inducible factor and angiogenesis - Allergy & Immunology
Allergic hyperreactivity is due to deficient immunoregulation, lack of microbial stimulation - Alzheimer Disease
New findings in the area of Alzheimer disease detailed - More from this issue of Proteomics Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
